跳至主要内容
临床试验/JPRN-UMIN000039418
JPRN-UMIN000039418招募中3 期

MAnagement of Direct Oral anticoagulant (DOACs) While Peripolypectomy Period: randomized A randomized controlled, mUlticenter trial - A randomized controlled trial on management of DOACs.

Osaka International Cancer Institute0 个研究点目标入组 400 人开始时间: 2020年2月8日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Person who has registered in this test. 2 Inflammatory bowel disease, colon polyposis. 3 Patients are receiving systemic steroids, antiplatelet drugs, and multiple anticoagulants continuously. (However, patients who can respond to antiplatelet drugs according to the guidelines of the Japanese Endoscopy Society can be registered.) 4 Blood coagulation dysfunction disease. 5 Women who are pregnant, may become pregnant, or are breastfeeding. 6 Patients with psychosis or psychiatric symptoms seem to have difficulty participating in the study. 7 Active bacterial and fungal infection (has a fever of 38.5 degrees or higher and is associated with bacterial infectivity by diagnostic imaging or bacteriological examination). 8 Uncontrolled hypertension. 9 Respiratory disease requiring continuous oxygen administration. 10 Dialysis. 11 Others who are judged inappropriate by the attending physician (eg, the prescribing physician of the anticoagulant determined that participation in this study was dangerous).

研究者

相似试验

A randomized controlled, multicenter trial... | 临床试验